Target intelligence / Profile preview

Uridine 5'-diphospho-glucuronosyltransferase (UGT)

Target
UGT
Molecular classification
Enzyme, Glycosyltransferase, Phase II drug-metabolizing enzyme
01

Overview

Uridine 5'-diphospho-glucuronosyltransferase (UGT) refers to a superfamily of membrane-bound glycosyltransferase enzymes primarily responsible for the glucuronidation reaction, a key Phase II metabolic process. UGTs transfer a glucuronic acid group from UDP-glucuronic acid to various substrates containing oxygen, nitrogen, sulfur, or carboxyl functional groups, including many drugs, toxins, dietary substances, and endogenous molecules such as bilirubin and steroid hormones[1][2][4][6]. This process increases substrate polarity and water solubility, facilitating excretion mainly via urine and bile and enabling the detoxification and clearance of potentially harmful substances from the body[1][2][6]. The human UGTs are divided into several families and subfamilies, most notably UGT1 and UGT2, which feature genetic polymorphisms that influence individual responses to drugs and susceptibility to toxicity[4][7]. Clinically, UGT enzymes play a significant role in drug metabolism, affecting the efficacy and safety of numerous therapeutic agents, including opioids, analgesics, anticonvulsants, antiviral drugs, and more[4][5]. Genetic defects in UGT enzymes (such as UGT1A1) can result in conditions like Crigler-Najjar syndrome and are also implicated in variations in drug response and toxicity[7]. UGTs are further implicated in cancer biology, both by inactivating drug therapies (leading to drug resistance) and potentially influencing cancer progression[5]. Species differences in UGT enzyme activity account for significant variations in drug safety profiles (e.g., cats lack certain UGTs, leading to unique toxicities)[1][4]. Pharmacogenetic testing of UGT genes is increasingly important for predicting drug response, tailoring therapies, and monitoring for adverse reactions[5][7].

Other names
glucuronosyltransferaseUDP-glucuronosyltransferaseUDPGTglucuronyltransferaseUDP-glucuronyl transferaseUDP-GT
02

Mechanism of action

Glucuronidation to increase solubility & elimination, Inactivation of drugs, Detoxification of endogenous and exogenous compounds

03

Biological functions

Xenobiotic metabolismDetoxificationDrug metabolismBilirubin conjugationHormone metabolismEndogenous compound metabolism
04

Disease associations

CancerDrug resistanceHyperbilirubinemia (e.g., Crigler-Najjar syndrome)JaundiceGenetic disordersOther
05

Safety considerations

Inter-individual variability in drug metabolism due to genetic polymorphismsRisk of toxicity from reduced glucuronidationDrug-drug interactionsAdverse drug reactionsSpecies differences in UGT activity
06

Interacting drugs

Opioids (e.g., morphine, codeine)

5 more in the full profile.

07

Biomarkers

UGT1A1 genotype or expression (for pharmacogenomic testing and predicting drug response/toxicity)UGT2B7 genotype

Beyond the preview

Go deeper on Uridine 5'-diphospho-glucuronosyltransferase (UGT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uridine 5'-diphospho-glucuronosyltransferase (UGT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call